PDCD1 and neoplasm: IRS combines TMB with four target gene expression measurements (PD-L1, PD-1, TOP2A, and ADAM12) from simultaneous, analytically valid, CGP plus quantitative transcriptional profiling (qTP) from formalin-fixed paraffin-embedded (FFPE) tumor specimens.